Preclinical Studies on Specific Gene Therapy for Recessive Retinal Degenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|10|5|389-403

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.10, Iss.5, 2010-10, pp. : 389-403

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AAV-Mediated Gene Supply for Treatment of Degenerative and Neovascular Retinal Diseases

By  

Current Gene Therapy, Vol. 10, Iss. 5, 2010-01 ,pp. : 371-380

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Gene Therapy in the Treatment of Retinal Diseases: A Review

By  

Current Gene Therapy, Vol. 17, Iss. 3, 2017-12 ,pp. : 194-213

Bentham Science Publishers

Access to resources Recommend Favorite

Pluripotent Stem Cells for Gene Therapy of Degenerative Muscle Diseases

By  

Current Gene Therapy, Vol. 15, Iss. 4, 2015-01 ,pp. : 364-380

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot topic: AAV-Mediated Gene Therapy for the Treatment of Retinal Diseases (Guest Editor: Fabienne Rolling)]

By  

Current Gene Therapy, Vol. 10, Iss. 5, 2010-10 ,pp. : 318-318

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Development of New Therapy for Glycogen Storage Diseases

By  

Current Gene Therapy, Vol. 15, Iss. 4, 2015-01 ,pp. : 338-347

Bentham Science Publishers

Access to resources Recommend Favorite